Vaccination
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18 years and over; both sexes; preserved cognition; be literate; receive only injection of the influenza vaccine via IM in the deltoid region
Exclusion criteria
Exclusion criteria: Participants reporting pain in the upper limbs; presence of injury or abrasions in the deltoid region; loss or alteration of sensation in the upper limbs, previous use of analgesics in the last six hours prior to immunization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Levels. Numerical variable, measured before and after application of the vaccine. Before the vaccine, participants will be asked the expected level of pain, based on a numerical scale from 0 to 10 points. Immediately after the vaccine, the level of pain during the application of the vaccine will be asked, based on the same numerical scale from 0 to 10 points. To interpret the scale, the following levels will be considered: 0-1 without pain; 1-3 mild pain; 3-6 moderate pain; 6-9 severe pain; 9-10 very intense pain;Anxiety level. Numerical variable, measured before and after application of the vaccine, from the visual analogue scale of anxiety, in which they should mark their level of anxiety along a horizontal line with a scale of 0-10 (0 = no anxiety and 10 = greatest possible anxiety) | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with the application of the vaccine = ordinal variable, measured on a 10-point Likert scale (0 = totally dissatisfied; 10 greatest satisfaction possible);Discomfort caused by the temperature of the frozen ice pack of the handheld device in contact with the skin, rated only by the IG participants, by a Likert scale (0 = “Not at all” to 10 = “Extremely uncomfortable”;Discomfort caused by vibration of the handheld device in contact with the skin, rated only by the IG participants, using a Likert scale (0 = “Not at all” to 10 = “Extremely uncomfortable”) | — |
Countries
Brazil